GAMA
Graticule Asia Macro Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-18,018
| Closed | -$923K | – | 73 |
|
|
2017
Q1 | $923K | Buy |
+18,018
| New | +$923K | 0.05% | 95 |
|
|
2016
Q1 | – | Sell |
-21,437
| Closed | -$2.02M | – | 49 |
|
|
2015
Q4 | $2.02M | Buy |
21,437
+9,437
| +79% | +$889K | 0.33% | 38 |
|
|
2015
Q3 | $964K | Buy |
+12,000
| New | +$964K | 0.11% | 53 |
|